Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Maintenance effect of a once-weekly regimen of a Selenium Disulfide-based shampoo in moderate-to-severe scalp seborrheic dermatitis after initial treatment with topical corticosteroid/salicylic acid.
Massiot P, Reygagne P, Chagnoleau C, Kanoun-Copy L, Pouradier F, Loussouarn G, Queille-Roussel C, Jouni H, Kerob D. Massiot P, et al. Among authors: reygagne p. Eur J Dermatol. 2023 Mar 1;33(S1):13-18. doi: 10.1684/ejd.2023.4401. Eur J Dermatol. 2023. PMID: 37098774 Clinical Trial.
Clinical benefit and tolerance profile of a keratolytic and hydrating shampoo in subjects with mild to moderate psoriasis. Results from a double-blind, randomized, vehicle-controlled study.
Massiot P, Pinto PC, Leclerc-Mercier S, Rasmont V, Piraccini BM, Rudnicka L, Reygagne P, Melo DF, Vano-Galvan S, Wu WY, Kerob D. Massiot P, et al. Among authors: reygagne p. J Cosmet Dermatol. 2023 Jul;22(7):2050-2053. doi: 10.1111/jocd.15693. Epub 2023 Mar 21. J Cosmet Dermatol. 2023. PMID: 36942745 Clinical Trial.
A Comparative Randomized Clinical Study Assessing the Efficacy of a 1% Selenium Disulfide-Based Shampoo versus 2% Ketoconazole Shampoo in Subjects with Moderate to Severe Scalp Seborrheic Dermatitis.
Barbosa V, Melo DF, Vañó-Galván S, Lutchmanen-Kolanthan V, Sant'Anna B, Leclerc-Mercier S, Reygagne P. Barbosa V, et al. Among authors: reygagne p. Skin Appendage Disord. 2024 Dec;10(6):497-504. doi: 10.1159/000539209. Epub 2024 Jun 18. Skin Appendage Disord. 2024. PMID: 39659649 Free article.
The Alopecia Areata Severity and Morbidity Index (ASAMI) Study: Results From a Global Expert Consensus Exercise on Determinants of Alopecia Areata Severity.
ASAMI Consensus Survey Study Group; Moussa A, Bennett M, Wall D, Meah N, York K, Bokhari L, Asfour L, Rees H, Abraham LS, Asz-Sigall D, Basmanav FB, Bergfeld W, Betz RC, Bhoyrul B, Blume-Peytavi U, Callender V, Chitreddy V, Combalia A, Cotsarelis G, Craiglow B, Dhurat R, Donovan J, Doroshkevich A, Eisman S, Farrant P, Ferrando J, Gadzhigoroeva A, Green J, Grimalt R, Harries M, Hordinsky M, Irvine A, Jolliffe V, Kaiumov S, King B, Lee J, Lee WS, Li J, Lortkipanidze N, McMichael A, Mesinkovska NA, Messenger A, Mirmirani P, Olsen E, Orlow SJ, Ovcharenko Y, Piraccini BM, Pirmez R, Rakowska A, Reygagne P, Rudnicka L, Corralo DS, Senna M, Shapiro J, Sharma P, Siliuk T, Starace M, Suchonwanit P, Takwale A, Tosti A, Vañó-Galván S, Visser WI, Vogt A, Wade M, Yip L, Zhou C, Sinclair R. ASAMI Consensus Survey Study Group, et al. Among authors: reygagne p. JAMA Dermatol. 2024 Mar 1;160(3):341-350. doi: 10.1001/jamadermatol.2023.5869. JAMA Dermatol. 2024. PMID: 38324292
Secukinumab in adult patients with lichen planus: efficacy and safety results from the randomized placebo-controlled proof-of-concept PRELUDE study.
Passeron T, Reinhardt M, Ehst B, Weiss J, Sluzevich J, Sticherling M, Reygagne P, Wohlrab J, Hertl M, Fazel N, Muscianisi E, Fan H, Hampele I, Compagno N. Passeron T, et al. Among authors: reygagne p. Br J Dermatol. 2024 Oct 17;191(5):680-690. doi: 10.1093/bjd/ljae181. Br J Dermatol. 2024. PMID: 38735684 Clinical Trial.
Physician- and Patient-Reported Severity and Quality of Life Impact of Alopecia Areata: Results from a Real-World Survey in Five European Countries.
Vañó-Galván S, Blume-Peytavi U, Farrant P, Reygagne P, Johansson E, Reed C, Marwaha S, Durand F, Piraccini BM. Vañó-Galván S, et al. Among authors: reygagne p. Dermatol Ther (Heidelb). 2023 Dec;13(12):3121-3135. doi: 10.1007/s13555-023-01057-0. Epub 2023 Oct 27. Dermatol Ther (Heidelb). 2023. PMID: 37889388 Free PMC article.
European expert consensus statement on the systemic treatment of alopecia areata.
Rudnicka L, Arenbergerova M, Grimalt R, Ioannides D, Katoulis AC, Lazaridou E, Olszewska M, Ovcharenko YS, Piraccini BM, Prohic A, Rakowska A, Reygagne P, Richard MA, Soares RO, Starace M, Vañó-Galvan S, Waskiel-Burnat A. Rudnicka L, et al. Among authors: reygagne p. J Eur Acad Dermatol Venereol. 2024 Apr;38(4):687-694. doi: 10.1111/jdv.19768. Epub 2024 Jan 2. J Eur Acad Dermatol Venereol. 2024. PMID: 38169088 Review.
Long-Term Use of Silybum marianum fruit extract Contributes to Homeostasis in Acne-Prone Skin-A 12-Month Follow-Up International "Real Life" Cohort Study.
Saurat JH, Reygagne P, Josse G, Hamidou Z, Bianovici S, Ramel F, Durbise E, Lovati C, Bellani E, Bystrzanowska D, Chlebus E, Kowalska-Oledzka E, D'Auzers G, Le Digabel J, Filiol J, Lauze C, Ortiz-Brugues A, Nocera T. Saurat JH, et al. Among authors: reygagne p. J Pers Med. 2022 Dec 31;13(1):96. doi: 10.3390/jpm13010096. J Pers Med. 2022. PMID: 36675757 Free PMC article.
87 results